Tesaro, Inc.
Tesaro, Inc., a prominent biopharmaceutical company headquartered in the United States, is dedicated to advancing cancer treatment through innovative therapies. Founded in 2010, Tesaro has made significant strides in the oncology sector, particularly in the development of targeted therapies and immuno-oncology solutions.
The company’s flagship product, Zejula (niraparib), is a groundbreaking treatment for ovarian cancer, distinguished by its ability to provide maintenance therapy for patients with recurrent disease. Tesaro's commitment to research and development has positioned it as a leader in the oncology market, with a focus on improving patient outcomes and quality of life.
With a strong presence in North America and Europe, Tesaro continues to expand its portfolio, aiming to address unmet medical needs in cancer care. Its dedication to innovation and patient-centric solutions underscores its reputation as a key player in the biopharmaceutical industry.
+62 vs industry average
Tesaro, Inc.’s score of 100 is higher than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Tesaro, Inc.?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has reduced its overall emissions by 19% since 0
Reported emissions
No reported emissions data is available for Tesaro, Inc. yet.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Tesaro, Inc.’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Tesaro, Inc. yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives

Science Based Targets Initiative
Inherited from GSK plc
Carbon Disclosure Project
Inherited from GSK plcThe Climate Pledge
Inherited from GSK plcUN Global Compact Climate Champions initiative
Inherited from GSK plcRE 100
Inherited from GSK plcClimate Action 100
Emissions comparison with industry peers
View similar organisationsUsage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project